Arizona: $26 Million in Marijuana Taxes Garnered in January 2025, Most Since January 2024

Arizona’s marijuana industry generated over $26 million in tax revenue in January.

There was $26,010,976 in tax revenue generated from licensed marijuana sales in January, according to the Arizona Department of Revenue. This is a notable increase over the $23.3 million garnered in December and the $23.7 million in November. January’s taxes brings the all-time total to $1,066,837,757.

In January, $16,770,312 of the taxes made came from the state’s 16% recreational marijuana excise tax, $7,696,300 from the 5.6% adult-use tax, and $1,533,049 from medical marijuana tax revenue. January marked the 38th consecutive month of marijuana tax revenue exceeding $20 million.
Continue reading

WA Bill to Revise Marijuana Advertising Laws Passes Second Senate Committee, Advances to Full Senate

Senate Bill 5206 has cleared another legislative hurdle, passing the Senate Ways and Means Committee yesterday after previously being approved by the Senate Committee on Labor and Commerce. The bill now advances to the full Senate for a vote.

Sponsored by Senators Drew MacEwen (R), Chris Gildon (R), and Derek Stanford (D), the legislation would modify Washington’s marijuana advertising regulations by expanding signage allowances for licensed retailers.

If enacted, SB 5206 would increase the number of exterior signs marijuana retailers can display from two to four. These signs must be attached to the building or placed in windows, with each limited to 1,600 square inches. Smaller signs under 512 square inches that do not include branding, such as those indicating store hours or ATM availability, would be exempt from advertising regulations.
Continue reading

New York Governor Proposes Reinstating Marijuana Odor as Evidence for Impaired Driving Tests, Facing Opposition From Legalization Advocates

Governor Kathy Hochul has introduced a proposal to reintroduce the smell of cannabis as a factor in determining reasonable cause for ordering blood tests in impaired driving cases.

New York Governor Catchy Hochul (photo credit: Dia Dipasupil/Getty Images).

New York’s recreational marijuana law, signed in 2021, explicitly barred police from using the odor of marijuana as justification for a traffic stop or vehicle search. Hochul’s proposal would amend that provision to allow law enforcement to cite “the odor of cannabis, burnt cannabis or other drug” as a reason to compel a court-ordered blood test if a driver is suspected of being impaired or involved in a crash.

Continue reading

Idaho Governor Signs Legislation Establishing Mandatory Minimum Fine for Marijuana Possession

Idaho Governor Brad Little signed House Bill 7 into law today, officially establishing a mandatory minimum fine for marijuana possession.

The measure, which previously passed the state Senate in a 27 to 8 vote after clearing the House 54 to 14, takes away judicial discretion to issue fines below a set amount.

Under Idaho’s existing law, possession of less than three ounces of marijuana is classified as a misdemeanor, carrying fines of up to $1,000. However, there has been no mandatory minimum penalty. With the governor’s signature, House Bill 7 changes that by setting a minimum fine of $300, ensuring that anyone convicted of possession will face at least that amount.

Continue reading

States Most Likely to Legalize Cannabis in 2025

24 states have legalized recreational marijuana. Here’s a look at the states most likely to become the 25th to legalize.

Legislative efforts to legalize recreational cannabis have been introduced in numerous states, but those listed below are the most likely to legalize cannabis this year.
Continue reading

Texas Bill Would Ban All THC-Containing Hemp Products, Limit Cannabinoids to CBD and CBG

A newly introduced bill in the Texas Legislature would prohibit the sale of consumable hemp products containing tetrahydrocannabinol (THC) and other cannabinoids besides cannabidiol (CBD) and cannabigerol (CBG).

Gummies made with hemp-derived Delta-8 THC.

Senate Bill 3, sponsored by Republican State Senator Charles Perry, was filed on Feb. 20 and referred to the Senate State Affairs Committee.

The measure would ban all products containing any form of THC, including those with delta-8 and delta-9 THC, which are currently legal under federal law as long as they contain no more than 0.3% THC by dry weight. It also establishes a mandatory registration system for businesses selling hemp-derived products and imposes penalties for violations.
Continue reading

Tennessee “Pot for Potholes Act” Garners New Sponsors

House Bill 703, known as the “Pot for Potholes Act,” has gained additional support in the Tennessee General Assembly, with State Representatives Gloria Johnson (D) and John Clemmons (D) signing on as cosponsors.

(Photo credit: David Paul Morris/Bloomberg).

Initially introduced earlier this month by State Representative Aftyn Behn (D), the bill would establish a regulated marijuana market in Tennessee, with tax revenue directed toward infrastructure improvements, particularly road maintenance and repairs.

The measure, which has been assigned to the Criminal Justice Subcommittee, would create a regulatory framework for the cultivation, processing, and retail sale of marijuana. The Tennessee Department of Agriculture would oversee licensing, product testing, and labeling standards. Under the proposal, individuals would be allowed to cultivate up to 12 plants for personal use without a license.
Continue reading

Study: CBD and CBG Show Potential in Combating HER2-Positive Ovarian Cancer

A new study published in the peer-reviewed journal ACS Omega shows that cannabinoids, including cannabidiol (CBD) and cannabigerol (CBG), could serve as promising treatments for HER2-positive ovarian cancer.

Researchers from Kasetsart University, Nation University, King Mongkut’s University of Technology, and the Thailand Science Park conducted kinase inhibition assays, surface plasmon resonance (SPR), molecular docking, and cell viability tests to evaluate the efficacy of CBD, CBG, and cannabinol (CBN) in targeting HER2-positive cancer cells.

According to the study, “SPR analysis revealed that cannabinoids bind strongly to HER2-tyrosine kinase (HER2-TK), with CBD showing the highest affinity (K D = 6.16 μM), significantly better than afatinib (K D = 26.30 μM), and CBG demonstrating moderate affinity (K D = 17.07 μM).” Additionally, “in kinase inhibition assays, CBG was the most potent inhibitor (IC50 = 24.7 nM), followed by CBD (IC50 = 38 nM), suggesting their ability to disrupt HER2-mediated signaling pathways.”
Continue reading

New West Virginia Bill Would Deschedule Marijuana, Psilocybin, and THC

A bill introduced today in the West Virginia Legislature seeks to remove marijuana, psilocybin, and tetrahydrocannabinols (THC) from the state’s list of controlled substances.

House Bill 2854, sponsored by Delegates Young, Pushkin, and Lewis, would fully deschedule these substances, meaning they would no longer be classified as controlled substances under state law. The measure has been referred to the House Health and Human Resources Committee, with further consideration by the Judiciary Committee if it advances.

If passed, the bill would mark a major shift in West Virginia’s approach to drug policy, particularly regarding marijuana and psychedelics. While some states have moved to reschedule these substances—placing them in a lower category of control—this proposal would remove them from scheduling altogether at the state level. However, the federal government still classifies all three as Schedule I drugs, meaning they are considered to have a high potential for abuse with no accepted medical use.
Continue reading

Study: Combination of CBD and THC May Reduce Migraine Symptoms

A study published in the journal Cephalalgia using an animal model found that a combination of CBD and THC may significantly reduce migraine symptoms.

Researchers from the University of Iowa, Leiden University Medical Center in the Netherlands, and the Department of Veterans Affairs Health Center in Iowa explored how these cannabinoids influence light aversion, pain sensitivity, and cortical spreading depolarization (CSD), a process linked to migraine pathology.

For the study, mice were given either CBD (100 mg/kg) or THC (1 mg/kg) alone, as well as combinations of CBD (1, 30, or 100 mg/kg) with THC (1 mg/kg) before exposure to migraine triggers such as calcitonin gene-related peptide (CGRP) and sodium nitroprusside (SNP). In separate trials, CSD was optogenetically induced in familial hemiplegic migraine (FHM1) mutant and wildtype mice to assess cannabinoid effects on migraine-related pain behaviors.
Continue reading